BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.


Journal

Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440

Informations de publication

Date de publication:
06 Sep 2024
Historique:
medline: 4 9 2024
pubmed: 4 9 2024
entrez: 4 9 2024
Statut: ppublish

Résumé

Kv1.3 is a multifunctional potassium channel implicated in multiple pathologies, including cancer. However, how it is involved in disease progression is not fully clear. We interrogated the interactome of Kv1.3 in intact cells using BioID proximity labeling, revealing that Kv1.3 interacts with STAT3- and p53-linked pathways. To prove the relevance of Kv1.3 and of its interactome in the context of tumorigenesis, we generated stable melanoma clones, in which ablation of Kv1.3 remodeled gene expression, reduced proliferation and colony formation, yielded fourfold smaller tumors, and decreased metastasis in vivo in comparison to WT cells. Kv1.3 deletion or pharmacological inhibition of mitochondrial Kv1.3 increased mitochondrial Reactive Oxygen Species release, decreased STAT3 phosphorylation, stabilized the p53 tumor suppressor, promoted metabolic switch, and altered the expression of several BioID-identified Kv1.3-networking proteins in tumor tissues. Collectively, our work revealed the tumor-promoting Kv1.3-interactome landscape, thus opening the way to target Kv1.3 not only as an ion-conducting entity but also as a signaling hub.

Identifiants

pubmed: 39231216
doi: 10.1126/sciadv.adn9361
doi:

Substances chimiques

Kv1.3 Potassium Channel 0
Tumor Suppressor Protein p53 0
STAT3 Transcription Factor 0
Reactive Oxygen Species 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

eadn9361

Auteurs

Elena Prosdocimi (E)

Department of Biology, University of Padova, Padova, Italy.

Veronica Carpanese (V)

Department of Biology, University of Padova, Padova, Italy.

Luca Matteo Todesca (LM)

Department of Biology, University of Padova, Padova, Italy.

Tatiana Varanita (T)

Department of Biology, University of Padova, Padova, Italy.

Magdalena Bachmann (M)

Department of Biology, University of Padova, Padova, Italy.

Margherita Festa (M)

Department of Biology, University of Padova, Padova, Italy.

Daniele Bonesso (D)

Department of Biology, University of Padova, Padova, Italy.

Mireia Perez-Verdaguer (M)

Department of Biology, University of Padova, Padova, Italy.

Andrea Carrer (A)

Department of Biology, University of Padova, Padova, Italy.
Department of Biomedical Sciences, University of Padova, Padova, Italy.

Angelo Velle (A)

Department of Biology, University of Padova, Padova, Italy.

Roberta Peruzzo (R)

Department of Biology, University of Padova, Padova, Italy.

Silvia Muccioli (S)

Department of Biology, University of Padova, Padova, Italy.

Davide Doni (D)

Department of Biology, University of Padova, Padova, Italy.

Luigi Leanza (L)

Department of Biology, University of Padova, Padova, Italy.

Paola Costantini (P)

Department of Biology, University of Padova, Padova, Italy.

Antonio Felipe (A)

Molecular Physiology Laboratory, Department de Bioquímica i Biomedicina Molecular, Institut de Biomedicina (IBUB), Universitat de Barcelona, Barcelona, Spain.

Michael J Edwards (MJ)

Department of Surgery, University of Cincinnati, Cincinnati, OH, USA.

Erich Gulbins (E)

Department of Molecular Biology, University of Duisburg-Essen, Essen, Germany.

Laura Cendron (L)

Department of Biology, University of Padova, Padova, Italy.

Chiara Romualdi (C)

Department of Biology, University of Padova, Padova, Italy.

Vanessa Checchetto (V)

Department of Biology, University of Padova, Padova, Italy.

Ildiko Szabo (I)

Department of Biology, University of Padova, Padova, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH